Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

By LabMedica International staff writers
Posted on 12 May 2025

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. More...

However, standard tests often fail to pinpoint the exact pathogen, leading to the need for multiple tests and resulting in treatment delays. A new solution aims to close this diagnostic gap, offering a single, fast, and convenient answer for identifying and managing suspected infectious pneumonia and other lung infections in these patients.

Karius (Redwood City, CA, USA) has introduced Karius Focus | BAL, a microbial cell-free DNA test that aids healthcare providers in accurately identifying the pathogens responsible for pneumonia and other lung infections. By leveraging microbial cell-free DNA technology, this test is designed to quickly pinpoint the cause of lung infections, improving the diagnostic yield compared to standard practices. With only 1 mL of BAL fluid, Karius Focus | BAL can detect and classify over 500 pathogens related to lung infections, delivering results within just one day of receiving the sample.

Obligate pathogens often present with vague symptoms or are masked by empirical treatments. Traditional diagnostic methods may fail to detect hard-to-identify organisms or fastidious microbes, leading to delays in obtaining a definitive diagnosis. Karius Focus | BAL addresses this issue by revealing these clinically significant pathogens. The microorganisms detected are categorized based on their likelihood of causing the infection. However, as with all microbiological tests, clinical context and additional diagnostic information are necessary for a precise interpretation.

“Lung infections are common and often lethal among immunocompromised patients yet current diagnostic tests fail to identify a specific infectious cause in most cases,” said Dr. Brad Perkins, Chief Medical Officer, Karius. “Karius has demonstrated that our plasma-based test (Karius Spectrum) significantly improves diagnostic yield among immunocompromised patients with pneumonia. We expect the Focus | BAL test to further improve diagnostic yield among immunocompromised patients who undergo bronchoscopy with bronchoalveolar lavage (BAL) for suspected pneumonia and other lung infections. The combination of Karius plasma- and BAL-based diagnostic tools, used alone or in combination, should substantially improve care.”

Related Links:
Karius


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.